Other studies have shown that celecoxib is able to reduce cell proliferation of the chronic myeloid leukemia (CML) cell line K562, which expresses COX-2 at the mRNA and protein level [89]. The gene discussed is PTGS2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.